.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Blogs
Clinical Trial Corner
CURE's 20th Anniversary Celebration
Podcasts
Publications
Recipes
Videos

Cancer TypeSee All >

Bladder
Breast
CLL
Kidney
Lung
MCL
Ovarian
Prostate
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise / Support
Contact
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

EP. 1: A Diagnosis of Exclusion

November 25th 2020

EP. 2: A Patient’s Initial Treatment for DLBCL

November 25th 2020

EP. 3: A DLBCL Relapse During COVID-19

November 25th 2020

EP. 4: CAR-T Cell Therapy for Relapsed/Refractory DLBCL

November 25th 2020

EP. 5: Relapsed DLBCL: CAR-T Cell Related Side Effects

November 25th 2020

EP. 6: CAR-T for DLBCL During COVID-19: A Caregiver’s Experience

November 25th 2020

EP. 7: Relapsed DLBCL: Recovering After CAR-T

November 25th 2020

EP. 8: Relapsed DLBCL: Assessing Response to CAR-T

November 25th 2020

EP. 9: CAR-T for Relapsed DLBCL: Advice for Patients & Caregivers

November 25th 2020

EP. 10: Managing DLBCL: A Team Effort

November 25th 2020

EP. 11: A Journey Through DLBCL: Cautiously Hopeful

November 25th 2020

Latest News

An Oncology Nurse With a Heart Like No Other

Educated Patient® MPN Summit Focus on Clinical Trials Panel: May 7, 2022

Tuesday Persists Until All Patients With Cancer are Taken Care Of

Trial Launches to Study a New Drug for B-Cell Malignancies

View More Latest News